ST
Seshu Tyagarajan
Chief Technology Officer

Seshu Tyagarajan insider trades: Candel Therapeutics (CADL) stock buys and sales

Chief Technology Officer, Candel Therapeutics Last trade Aug 17, 2026 17 Form 4 filings
$154K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Seshu reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 17, 2026CADL↓ Sell$84K
Jun 29, 2026CADL↓ Sell$70K
Mar 17, 2025CADL↓ Sell$276K
Jan 15, 2025CADL↓ Sell$103K
Jan 8, 2025CADL↓ Sell$120K
Nov 29, 2024CADL↓ Sell$93K
Jul 17, 2024CADL↓ Sell$96K
Jul 11, 2024CADL↓ Sell$80K
Dec 9, 2022CADL↑ Buy$25K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CADL insiders

Open-market trades in the last 12 months

About Seshu Tyagarajan's insider trades

Seshu Tyagarajan is Chief Technology Officer at Candel Therapeutics (CADL). Since Dec 9, 2022, Seshu has reported 1 open-market purchase worth $25K and 8 sales worth $922K on SEC Form 4. In the last 12 months: 2 sales ($154K).

Their filings also include grants and awards (7 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CADL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.